ClinicalTrials.gg
Sign In

Vulvodynia clinical trials

The registry lists 117 studies for Vulvodynia across more than 10 countries. 21 are recruiting or about to start. 92 of them are mainly about Vulvodynia (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-06.

Get an email when these change. Save the Vulvodynia studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed
67
Recruiting
13
Terminated
13
Status unknown
7
Not yet recruiting
7
Active, not recruiting
6

Phase

Phase 2
16
Phase 3
12
Phase 4
2
Phase 1
1

Where

United States
47
Canada
21
Israel
11
Sweden
8
France
5
Norway
4

Who runs them

Université de Sherbrooke (8) · Western Galilee Hospital-Nahariya (7) · William Beaumont Hospitals (5) · University of British Columbia (4) · Uppsala University (3) · University of California, Los Angeles (3) · Centre Hospitalier Universitaire de Besancon (3) · Oregon Health and Science University (3)

What is being tested here

Drugs under test in Vulvodynia studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

DrugOpenPhase 3All
Naltrexone202
Testosterone111
Ketotifen101
Botulinum toxin type A034
Gabapentin002
Pudafensine001
Nortriptyline001
Clobetasol011
Enoxaparin001
Milnacipran011

Coming up

1phase 3 study under way
13studies finish main data collection within a year

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

The 10 nearest

Who these studies take

Of the 13 Vulvodynia studies recruiting now, 8 (62%) set no upper age limit and 5 (38%) stop at 75 or younger. 0 (0%) take children under 18. 12 (92%) are for women only and 0 (0%) for men only; 2 (15%) take healthy volunteers.

Recruiting studies that take each age, of 13
AgeWomenMen
100 (0%)0 (0%)
1812 (92%)1 (8%)
3013 (100%)1 (8%)
4012 (92%)1 (8%)
5011 (85%)1 (8%)
659 (69%)1 (8%)
759 (69%)1 (8%)
858 (62%)1 (8%)

Across all 117 studies, recruiting or not: 60% stop at 75 or younger and 54% at 65; 4% take children; 94% are for women only and 0% for men only; 26% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

How long Vulvodynia studies take

Of 32 interventional studies with no phase under Vulvodynia, half reached primary completion within 36 months of starting, counting those still running.

Start to primary completionEvery sponsorIndustryNon-industry
Interventional, no phase36 mo16–56 · 32 studies—36 mo16–56 · 32 studies

Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out

What changed recently

From the registry's own updates since Oct 14, 2026.

Stopped1

Newly registered2

Studies

Recruiting first, then most recently updated. Showing 50 of 117. Browse all 117 → or search them.